Blog / Archives
Biotech Bull Market-Trends to Watch #2: ETF Review-FBT XBI
Biotech and Healthcare ETFs Hit An All Time High--Another Rally Coming Today 3/20 M&A: Recent buy-outs of Cubist (CBST) for $9.5B and Pharmacyclics (PCYC) for $21B have raised the valuation bar....
Rayno Life Science Portfolios: AMGN,CLVS,ILMN,RGEN,TMO…Update 3/18
March 18-Stealth Rally With A Tempered Tape In Biotech NASDAQ up 0.92% Biotech stocks lagged the surprising FED rally today maybe because money was moving to other sectors.This bears close watching...
Rayno Life Sciences DX and Tools Update: 2015 Q1 Winners ALR,FMI,HOLX
Diagnostic Stocks rally with NASDAQ and Small Caps -IWM Up 1.66% Life Science Tools and Diagnostics stocks are a tad off their one year highs hit by dollar strength and disappointing revenue growth...
What Sell-Off? Biotechs Cruise: CLVS, SGEN
Stocks in Sharp Sell-Off on Potential FED Rate Increase and Strong Dollar Deflation is Still Lurking S&P Down 1.7%, NASDAQ down 1.67% Biotech stocks avoided the severe sell-off today apparently...
Biotechs Roaring Back: Do They Sense A Deal? Update -1 ABBV/PCYC
Whoa! $261.25 And the winner is Abbvie (ABBV) for $21B! Pharmacyclics Buzz Is Back Biotech stocks covered the green screen today, despite a listless general market, driven by deal talk regarding...
Mid Cap Emerging Biopharmaceutical Companies: Valuations Do Matter for M&A
Update-1... On Onyx $10.4B Buyout By Amgen (AMGN) Valuation Models for Biopharma Stocks -M&A Update In October 2013 we compared emerging biotech stocks after the acquisition of Onyx...
SierraSnow Blog 2/27-3/3/15…. More Snowpack
More snow coming this weekend: Jet Stream in Place earth :: an animated map of global wind, weather, and ocean conditions National Maps - NOAA's National Weather Service 814prcp.new.gif 719×759...
Rayno Biopharmaceutical Stocks: PCYC Buzz Drive Biotechs Higher… Update-1
2/27 Friday After a big February biotechs turned red today with major ETFs off about 1%. In light of recent M&A talk about Pharmacyclics, Inc. (PCYC) at Market Cap of $16.6B we will look at...
Rayno Dx and Tools: Update EXAS
Valuation Does Matter If Revenue Growth Slows Last week we posted a YTD summary of our diagnostics and tools focus stocks. Three stocks that are up over one year but have been weak in 2015. We said...
SierraSnowBlog: Tiny Bit of Relief Coming Up…Update 2/23 Powder Day
2/23/15 I was at Mammoth Mountain today with light winds, partly sunny, temp in 20s. There was 8-12 in of light powder with great runs off Chairs 1, 2, 3 and 12 in early am. Stay tuned for March...